Literature DB >> 17407232

Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display.

Rotraud Meyringer1, Elena Neumann, Martin Judex, Michael Landthaler, Frank Kullmann, Jürgen Scholmerich, Steffen Gay, Ingo H Tarner, Oliver Distler, Ulf Müller-Ladner.   

Abstract

OBJECTIVE: To identify genes that are differentially expressed in systemic sclerosis (SSc) fibroblasts of clinically involved and noninvolved skin compared to normal dermal fibroblasts, using RNA arbitrarily primed-polymerase chain reaction (RAP-PCR) for differential display.
METHODS: We examined 12 fibroblast cultures derived from clinically involved skin, 3 fibroblast cultures from noninvolved skin, and 4 fibroblast cultures from healthy skin. After extraction of total RNA, the first step of RAP-PCR was performed using different arbitrary 10-12-base primers for first-strand cDNA synthesis. Second-strand synthesis was achieved by cycling using different arbitrary 10-base primers, followed by sequence analysis of the amplified fingerprint products. The resulting sequences were aligned to the GenBank database using Blast Search. Confirmation of differential expression was performed with specific primers using real-time PCR.
RESULTS: Using 8 different primer combinations, in total 48 cDNA were differentially expressed between SSc and healthy dermal fibroblasts. Sequence analysis identified distinct PCR products, which were overexpressed in SSc as highly homologous to gene segments of gremlin protein, lysyl oxidase, c-cbl proto-oncogene, an estrogen-responsive element, fibronectin, and collagen type XIIa1 precursor.
CONCLUSION: Our results show that RAP-PCR is a suitable method to identify differentially expressed genes in SSc fibroblasts. Further, we identified genes that have not yet been described in the pathophysiology of SSc and that may be involved in matrix synthesis and cellular interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407232

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Fibrosis--a lethal component of systemic sclerosis.

Authors:  Yuen Yee Ho; David Lagares; Andrew M Tager; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2014-04-22       Impact factor: 20.543

2.  Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis.

Authors:  Remedios Castello-Cros; Diana Whitaker-Menezes; Alex Molchansky; George Purkins; Louis J Soslowsky; David P Beason; Federica Sotgia; Renato V Iozzo; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

3.  B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease.

Authors:  Emanuel Della-Torre; Elena Rigamonti; Cory Perugino; Simona Baghai-Sain; Na Sun; Naoki Kaneko; Takashi Maehara; Lucrezia Rovati; Maurilio Ponzoni; Raffaella Milani; Marco Lanzillotta; Vinay Mahajan; Hamid Mattoo; Ivan Molineris; Vikram Deshpande; John H Stone; Massimo Falconi; Angelo A Manfredi; Shiv Pillai
Journal:  J Allergy Clin Immunol       Date:  2019-07-15       Impact factor: 10.793

4.  Incisional hernia recurrence through genomic profiling: a pilot study.

Authors:  R Calaluce; J W Davis; S L Bachman; M M Gubin; J A Brown; J D Magee; T S Loy; B J Ramshaw; U Atasoy
Journal:  Hernia       Date:  2012-05-31       Impact factor: 4.739

5.  Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches.

Authors:  Qiao Wang; Guoshan Shi; Yun Zhang; Feilong Lu; Duoli Xie; Chengping Wen; Lin Huang
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

Review 6.  Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases.

Authors:  Lara Perryman; Steven G Gray
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

7.  Serum lysyl oxidase concentration increases in long-standing systemic sclerosis: Can lysyl oxidase change over time?

Authors:  Mohammad Hassan Jokar; Simin Jafaripour; Nafiseh Abdollahi; Maryam Nazemipour; Maliheh Moradzadeh; Mohammad Ali Mansournia
Journal:  Arch Rheumatol       Date:  2021-10-18       Impact factor: 1.007

8.  Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis.

Authors:  Keiko Aida-Yasuoka; Christine Peoples; Hidekata Yasuoka; Pamela Hershberger; Katelynn Thiel; Jane A Cauley; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Arthritis Res Ther       Date:  2013-01-10       Impact factor: 5.156

9.  Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine.

Authors:  Katri Koli; Eva Sutinen; Mikko Rönty; Pia Rantakari; Vittorio Fortino; Ville Pulkkinen; Dario Greco; Petra Sipilä; Marjukka Myllärniemi
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

10.  Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis.

Authors:  Laura Duffy; John Henderson; Max Brown; Stefan Pryzborski; Nicola Fullard; Lena Summa; Jorg H W Distler; Richard Stratton; Steven O'Reilly
Journal:  Front Cell Dev Biol       Date:  2021-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.